Clinical Trials Logo

Retinal Detachment clinical trials

View clinical trials related to Retinal Detachment.

Filter by:

NCT ID: NCT01767038 Completed - Retinal Detachment Clinical Trials

DOREFA (Retinal Detachment: Function and Anatomy)

DOREFA
Start date: November 2011
Phase: N/A
Study type: Interventional

Patients with retinal detachment do not always recover good visual function. Sometimes simple causes are responsible. Other causes can only be discovered thanks to high-resolution imaging provided by the latest generation of OCT. This study is possible thanks to surgical teams who have a strong recruitment potential, with the experience of a joint project in 2007-2008 (PHRC national - Etude DOREMY, Etude FRIENDS) to define more strict intervention criteria. The principal objective of this study is to better define with regard to time: - The onset of surgically curable or transient macular affections, and losses in visual acuity that can be qualified as "explained" - But above all to better understand the relationships between anatomical analyses obtained using OCT and autofluorescence and functional analysis using visual acuity and microperimetry. - In the near future, two techniques (OCT and microperimetry) will certainly become essential tools in the evaluation of macular function. Better understanding of these relationships is the first necessary step in any study concerning the therapeutic prevention of retinal lesions related to retinal detachment: This study will make it possible to define criteria for the evaluation of anatomical and functional recovery, their relationship with each other and finally their evolution over time. This is an essential first phase before possible therapies can be evaluated.

NCT ID: NCT01722656 Completed - Clinical trials for Submacular Vascularized Pigment Epithelial Detachments

Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment

EVEN
Start date: November 2012
Phase: Phase 4
Study type: Interventional

This study will evaluate the use of intravitreal aflibercept (anti-VEGF therapy) in patients with a type of macular degeneration known as vascularized pigment epithelial detachment. Previous studies have shown a generally poor outcome in treating this difficult to treat form of wet macular degeneration. More recently, multiple pilot studies have shown positive benefits to using anti-VEGF therapy. This study will evaluate the safety and efficacy of treating vascularize pigment epithelial detachment associated with wet macular degeneration with intravitreal aflibercept injection.

NCT ID: NCT01716507 Completed - Retinal Detachment Clinical Trials

23 Gauge and 20 Gauge Vitrectomy for Rhegmatogenous Retinal Detachments

Start date: April 2008
Phase: N/A
Study type: Interventional

This study is a comparison (23 gauge vs 20 gauge instrumentation) of surgical instrumentation for retinal detachment repair.

NCT ID: NCT01639209 Completed - Clinical trials for Rhegmatogenous Retinal Detachment

Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment

Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this research study is to compare the outcomes of pneumatic retinopexy with the outcomes of vitrectomy (with or without scleral buckle) for the management of retinal detachment, in terms of anatomical success, functional success and impact on patient quality of life.

NCT ID: NCT01628354 Completed - Clinical trials for Choroidal Neovascularization

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Start date: February 2008
Phase: Phase 4
Study type: Interventional

The investigators hypothesize that it is safe and effective to treat patients with choroidal neovascularisation (abnormal blood vessels growing under the retina) secondary to causes other than age related macular degeneration (AMD) and pigment epithelial detachments (blisters of fluid under the retina) secondary to AMD with ranibizumab (Lucentis). These groups of patients have to date been excluded from the multicentre trials demonstrating significant benefit of Ranibizumab in the treatment of AMD.

NCT ID: NCT01587794 Completed - Clinical trials for Rhegmatogenous Retinal Detachment

Topographic Changes of Retinal Layers After Resolution of Acute Retinal Detachment

Start date: April 2010
Phase: N/A
Study type: Observational

Experimental retinal detachment and reattachment models have demonstrated the recovery process of successfully reattached retina. However, optical coherence tomography analysis of each retinal layers following retinal reattachment has not been investigated This study investigated changes in thickness profiles of retinal layers after resolution of recent-onset rhegmatogenous retinal detachment (RRD) using optical coherence tomography images.

NCT ID: NCT01487070 Completed - PDR Clinical Trials

A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

Start date: April 2011
Phase: Phase 1
Study type: Interventional

Primary objective of this trial will be to evaluate the safety and efficacy of intravitreal injections of Macugen (pegaptanib sodium) when given at least 7-14 days prior to vitrectomy in subjects with tractional retinal detachment (with or withoutmacular involvement) secondary to proliferative diabetic retinopathy. Secondary objective is to evaluate regression of neovascularization and progression of macular traction utilizing OCT and fundus photographs.

NCT ID: NCT01480505 Completed - Clinical trials for Postoperative Complications

Primary Vitrectomy for the Treatment of Retinal Detachment in Highly Myopic

Start date: October 1999
Phase: N/A
Study type: Observational

Purpose: To assess the functional and anatomical outcome of primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment (RRD) in highly myopic eyes with axial length over 30 mm. Methods Design: Retrospective single center series. Setting: University Hospital. Patients: High myopic patients treated with primary vitrectomy without scleral buckling for a rhegmatogenous retinal detachment. Outcome measures: Anatomical success rate with complete reattachment of the retina without silicone oil tamponade and postoperative best-corrected visual acuity (BCVA).

NCT ID: NCT01454466 Completed - Retinal Detachment Clinical Trials

Partial Posterior Hyaloidectomy in Macular Surgery

Start date: November 2009
Phase: Phase 1
Study type: Interventional

To evaluate the effect of partial posterior hyaloidectomy on preventing iatrogenic retinal breaks related to induction of a posterior vitreous detachment

NCT ID: NCT01446367 Completed - Clinical trials for Rhegmatogenous Retinal Detachment

Corneal Changes After Retinal Surgery

Start date: February 2010
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the corneal changes after performing 20 gauge vitrectomy associated with scleral buckling for the treatment of rhegmatogenous retinal detachment.